Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-004631-77Phase 4Completed
Phase 4, open-label, single-arm trial of insulin degludec in diabetes mellitus type 1 (T1D), sponsored by Medical University of Graz. Primary endpoints: Absence of hypoglycemia during exercise and Absence of post-exercise hypoglycemia. Started Jan 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-004631-77.